COMPARISON OF IMMUNOMODULATIVE EFFECTS OF HISTAMINE-2 RECEPTOR ANTAGONISTS IN GASTRIC-CANCER PATIENTS - FOCUS ON THE LYMPHOBLASTOGENESIS AND CYTOTOXICITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS
Kb. Hahm et al., COMPARISON OF IMMUNOMODULATIVE EFFECTS OF HISTAMINE-2 RECEPTOR ANTAGONISTS IN GASTRIC-CANCER PATIENTS - FOCUS ON THE LYMPHOBLASTOGENESIS AND CYTOTOXICITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS, International journal of immunopharmacology, 16(12), 1994, pp. 985-993
A proposed mechanism of the immunomodulative effects of histamine-2 re
ceptor antagonist (HZ-RA) has been considered to be the inhibition of
suppressor T-lymphocyte activity, an increase in interleukin-2 product
ion of helper T-lymphocytes, and an enhancement of natural killer cell
activity. Since there is a lack of comparative data about the immunom
odulative effects of various H2-RAs, cimetidine, ranitidine and famoti
dine on peripheral blood mononuclear cells (PBMC), study of the compar
ison of the actions of H2-RA will be required. We compared the immunom
odulative effect of each H2-RA on PBMC in patients with gastric cancer
. DNA synthesis, cytotoxicity of PBMC against K562 cells and gastric c
ancer cell lines, and the levels of supernatant soluble interleukin-2
receptor (sIL-2R) were measured after the addition of each HZ-RA, resp
ectively. Increased suppressor cell activities were attenuated and res
tored to the levels of normal controls by the addition of cimetidine t
o H2-RA. Statistically significant lymphoblastogenesis and cytotoxicit
y against K562 cells were observed only in cimetidine-treated PBMC (P<
0.05). Such effects were not observed in ranitidine- or famotidine-tre
ated PBMC. Neither cimetidine- nor ranitidine-activated PBMC showed an
y significant cytotoxicity against gastric cancer cells. Significantly
increased levels of sIL-2R were found in supernatants obtained from c
ulture flasks treated with cimetidine or ranitidine and phytohemagglut
inin (P<0.01). A significant correlation was found between the cytotox
icity of cimetidine- or ranitidine-treated PBMC and supernatant sIL-2R
(P<0.05). In conclusion, the most strongly modulative substance among
H2-RAs was cimetidine and the least modulative drug was famotidine. T
hese results might be due to their structural differences. The immunol
ogical effects of H2-RA are unlikely to be mediated via specific inter
action at the H2 receptor.